COMIRNATY
COMIRNATY
Discontinued
DIN Number
02522454
Drug Class
Human
Market Date
Nov 22, 2021
Company
HC
BioNTech Manufacturing GmbH
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02522454
AIG Number0162621003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TOZINAMERANActive
Strength: 10 MCG / 0.2 ML
Monograph: TOZINAMERAN